As China’s easing of COVID-19 restrictions starts to take shape, the focus of investors is increasingly shifting from frenzied stock bets to longer-term plays, such as consumer and healthcare shares.
Money managers are zeroing in on companies that are expected to benefit from a reopening-led economic recovery instead of travel and catering firms, whose shares have jumped sharply in the early days of the rally.
“With the trajectory of the economy set to be back on track, it is time to shift focus from stocks primed to jump on short-term changes,” Shenzhen Zhengyuan Investment Co (深圳正圓投資) fund manager Hua Tong (華通) said. “We can now afford to take the longer-term view to seek out opportunities — and the biggest unrealized opportunity is in the consumer sector.”
Photo: AFP
Recent updates from health authorities include allowing some low-risk COVID-19 cases to isolate at home and loosening curbs in select cities, with the official rhetoric on the disease also coalescing around a softer tone.
“The reopening trade will be led by consumption and healthcare in the coming months,” Snowball Wealth (雪球投資) fund manager Li Changmin (李昌民) said. “Guangzhou’s surprise reopening, even with its high case count, has fired the first shot, and this could expedite the timeline for ending COVID zero.”
Li expects a full reopening to occur before annual parliamentary meetings in March next year.
Photo: Reuters
“Life returning to normal would mostly benefit the blue-chip names which have suffered huge valuation discounts, whereas the upside for travel and airlines stocks has been mostly priced in,” he said.
The CSI 300 Index’s consumer staples subindex was trading close to 22 times its one-year forward earnings, compared with an average of almost 27 times over the past three years.
The initial leg of the reopening trade has seen more volatile stocks lead the charge. Shares linked to the travel, catering and pharmaceutical industries have been among the prime beneficiaries.
More broadly, the Hang Seng China Enterprises Index soared 29 percent in Hong Kong last month, the most since 2003.
The benchmark CSI 300 Index jumped almost 10 percent in its best performance since July 2020.
The rally has eased since, with the gauges little changed over two sessions this month.
Pegasus Fund Managers Ltd (東驥基金管理) managing director Paul Pong (龐寶林) favors consumer stocks such as automakers, which are expected to beat their peers when spending picks up.
“Big tech firms that have been laggards, like Alibaba (阿里巴巴) and Tencent (騰訊), will also outperform as they have high beta and benefit directly from a consumption recovery,” Pong said.
However, some investors still see room for a further rally in the traditional cohort of reopening plays.
BNP Paribas SA Asian equity strategist Manishi Raychaudhuri said that stocks related to tourism, restaurant chains, e-commerce, Macau gaming and retail-focused real-estate investment trusts might notch up more gains.
“Other Asian markets, like Thailand, also offer interesting exposures to this theme — through airports and hotel chain stocks,” he said.
Overall, an increasing number of investors are setting their sights on the longer-term play even though China’s exit from its “zero COVID-19” policy might be fraught with challenges.
“Reversing course is going to be like walking on a tightrope, full of adjustments in both directions in the search for the most desirable solution,” said Liu Xiaodong (劉小東), a partner at Shanghai Power Asset Management Co (上海樸沃資產管理).
“This means that many of the reopening plays may be prone to flip-flop and end up moving horizontally,” Liu said. “If anything, I think healthcare does have potential, whichever way the tide turns in the short term, people are going to need treatment.”
Among the rows of vibrators, rubber torsos and leather harnesses at a Chinese sex toys exhibition in Shanghai this weekend, the beginnings of an artificial intelligence (AI)-driven shift in the industry quietly pulsed. China manufactures about 70 percent of the world’s sex toys, most of it the “hardware” on display at the fair — whether that be technicolor tentacled dildos or hyper-realistic personalized silicone dolls. Yet smart toys have been rising in popularity for some time. Many major European and US brands already offer tech-enhanced products that can enable long-distance love, monitor well-being and even bring people one step closer to
Malaysia’s leader yesterday announced plans to build a massive semiconductor design park, aiming to boost the Southeast Asian nation’s role in the global chip industry. A prominent player in the semiconductor industry for decades, Malaysia accounts for an estimated 13 percent of global back-end manufacturing, according to German tech giant Bosch. Now it wants to go beyond production and emerge as a chip design powerhouse too, Malaysian Prime Minister Anwar Ibrahim said. “I am pleased to announce the largest IC (integrated circuit) Design Park in Southeast Asia, that will house world-class anchor tenants and collaborate with global companies such as Arm [Holdings PLC],”
Sales in the retail, and food and beverage sectors last month continued to rise, increasing 0.7 percent and 13.6 percent respectively from a year earlier, setting record highs for the month of March, the Ministry of Economic Affairs said yesterday. Sales in the wholesale sector also grew last month by 4.6 annually, mainly due to the business opportunities for emerging applications related to artificial intelligence (AI) and high-performance computing technologies, the ministry said in a report. The ministry forecast that retail, and food and beverage sales this month would retain their growth momentum as the former would benefit from Tomb Sweeping Day
Thousands of parents in Singapore are furious after a Cordlife Group Ltd (康盛人生集團), a major operator of cord blood banks in Asia, irreparably damaged their children’s samples through improper handling, with some now pursuing legal action. The ongoing case, one of the worst to hit the largely untested industry, has renewed concerns over companies marketing themselves to anxious parents with mostly unproven assurances. This has implications across the region, given Cordlife’s operations in Hong Kong, Macau, Indonesia, the Philippines and India. The parents paid for years to have their infants’ cord blood stored, with the understanding that the stem cells they contained